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burden of disease in The Netherlands. METHODS: Review of
the literature. To select which interventions to include, a two-step
approach was followed. In the ﬁrst step, a longlist with possible
interventions was created, based on a systematic search of the
economic evaluations of relative new preventive interventions. In
the second step, all interventions that a) were not systematically
implemented in The Netherlands during the study; b) were rel-
evant for the Dutch situation; and c) had at least three high
quality economic evaluations with base case ICERs of around or
below € 20,000 per QALY gained, were selected. For all included
interventions a general appraisal of four aspects (effectiveness,
cost-effectiveness, transferability and feasibility for implementa-
tion) was performed. RESULTS: Twenty-eight preventive inter-
ventions were included. Twenty-two of these were from the ﬁeld
of disease prevention, including eight vaccinations and seven
screening programmes. Three interventions concerned health
promotion, and three interventions concerned health protection.
Remarkably, the majority of the included interventions lacked a
convincing evidence-base for effectiveness. The results were gen-
erally not directly transferable to the Dutch context and there
were considerable concerns with respect to implementation of
these interventions in The Netherlands. CONCLUSIONS: Only
20% of the included preventive interventions were from the
domain of health promotion or health protection. This propor-
tion reﬂects the lack of economic evaluations in these domains of
prevention, not that interventions in these domains are generally
not cost-effective. Evidence of cost-effectiveness of preventive
interventions in foreign countries can poorly support policy deci-
sion making at the national and local level.
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OBJECTIVES: The General Practice Research Database (GPRD)
is a premier data source for research but has limited detail on
hospitalisations. UK Hospital Episode Statistics (HES) provide
detailed health care resource use within secondary care. The aims
of this project were to link primary care data with hospital
admissions data at the patient level. METHODS: For contribut-
ing practices in England who gave explicit consent, GPRD
patient data was linked to English HES data from April 2001 to
March 2006 using NHS number, or using date of birth, gender
and postcode; via a trusted third party (TTP) with full ethical and
operational approvals. A descriptive analysis was conducted on
the linked HES data including basic counts and univariate sta-
tistics. Analysis of concordance between data sets relating to
disease diagnosis was undertaken on a ﬁfty patient sample.
RESULTS: Two hundred practices consented and provided
linkage data to the TTP. There were 2,009,920 GPRD patients
registered within the HES data, 99.3% with a valid NHS iden-
tiﬁer. Of these, 1,242,242 (62%) had no record of hospitalisation
during this period. The remaining 754,406 patients had
2,028,473 hospital spells comprised of 2,285,718 episodes.
Mean duration of hospitalisation was 5.76 days (median = 2
days). Augmented care (ICU) stays were recorded for 2.6% of
patients with mean duration = 4.97 days (median = 3 days).
Hospital diagnoses were concordant for >75% of diagnoses
reviewed. CONCLUSIONS: A very high proportion of eligible
patients in GPRD were linked to HES using their NHS identiﬁer.
Initial descriptive analyses show a signiﬁcant proportion of
GPRD patients have one or more hospitalisation with good
concordance of diagnosis between the two sources. The addition
of HES data with duration and information on augmented care
will facilitate the understanding of resource use in both hospi-
talisations and primary care which can result in more robust
estimates for economic modelling and other research.
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OBJECTIVES: In order to prevent chronic diseases, individuals
should actively pay more attention to their own health conditions
and not merely rely on the medical system passively. The purpose
of this study attempted to investigate the impact of individual
health behaviors, speciﬁcally the exercise behavior, to his/her
health-related quality of life from “positive” viewpoints by
applying Deci & Ryan’s self-determination theory (SDT).
METHODS: Four hundred and thirty-two undergraduate stu-
dents at National Taiwan University participated in this study.
Four sets of questionnaires concerning the basic psychological
needs in exercise, health motivation, exercise behavior, and
quality of life (i.e., WHOQOL-BREF) were used in this study.
The quantitative analysis of the questionnaires was conducted
through descriptive statistics and structural equation modeling
(SEM) in order to indicate any relationships between two latent
factors or a latent factor and a manifested variable. RESULTS:
Results of this study showed that there were stronger relation-
ships between the basic psychological needs in exercise, the
intrinsic health motivation, the exercise behavior, and the psy-
chological domain of quality of life. Furthermore, the basic psy-
chological needs in exercise were also linked directly to the
psychological domain of quality of life. The results also indicated
that the viewpoint of SDT can be used for predicting the health-
related quality of the life. There was a relationship between the
basic psychological needs in exercise and health-related quality
of life. CONCLUSIONS: To conclude, the study shows that the
satisfaction of three basic psychological needs can increase per-
sonal intrinsic health motivation, enable people to care about
their own health more voluntarily, increase the possibility to do
health behavior, and then lead to a better health-related quality
of life.
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OBJECTIVES: To analyze clinical pharmacists’ interventions and
determine classiﬁcation types as well as clinical relevance.
METHODS: This was a 5-month (January to May 2008) retro-
spective intervention study conducted at a 500-bed tertiary
teaching hospital in Muscat, Oman. A standard manual docu-
mentation form was used to capture the interventions. Interven-
tions were classiﬁed into ﬁve groups, namely; drug choice, drug
regimen, monitoring, information, and prescribing issues. Clini-
cal relevance was related to whether efﬁcacy or toxicity was
either improved or reduced. The outcome of each intervention
was categorized as accepted, rejected or unknown according to
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the prescribing physician’s response. The pharmacists evaluated
the clinical signiﬁcance of the interventions based on their own
clinical judgments. Analyses were performed using descriptive
statistics. RESULTS: A total of 504 interventions were docu-
mented over the 5-month study period. On average each inter-
vention took 15  14 (median, 10) minutes, ranging from 1
minute to 3 hours. The most common interventions performed
were on drug regimen change (n = 237; 47%), drug choice
(n = 128; 25%) and drug information issues (n = 106; 21%).
Dose change (n = 153; 30%) and patient education (n = 54;
11%) were the most frequent interventions performed in the
drug regimen change and drug information categories, respec-
tively. The most common indications for which interventions
were made were infectious (n = 100; 20%) and respiratory
(n = 77; 15%) diseases. Efﬁcacy was improved and toxicity
avoided in 38% (n = 193) and 28% (n = 140) of the interven-
tions, respectively. Potential fatalities or end-organ damage was
avoided in 1.6% (n = 8) of the cases while interventions of major
signiﬁcance was recorded in 43% (n = 215) of the interventions.
CONCLUSIONS: The data show that clinical pharmacists play
an important role in drug safety and efﬁcacy to optimize phar-
maceutical care as part of the multi-disciplinary team approach
in the hospital.
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OBJECTIVES: To evaluate the operation of the Afternoon Out-
patients Clinics (AOC) at the University General Hospital of
Larissa. The operation of AOC is a relatively new institution in
the country, introduced in 2001 by the 2889 NHS reform law.
METHODS: Descriptive and comparative analysis of data from
2002 of the AOC introduction up to 2006 is done. Data emanate
from the 5th Region Health Authority. Clinical and economic
indicators have been used for the evaluation based on medical
specialties, diagnostic and professional categories, operational
activities and ﬁnancial inputs and outputs. RESULTS: A progres-
sive increase in AOC visits has been estimated, reaching 82% of
total hospital outpatient visits with surgery accepting the bigger
volume of visits. Their income presents a 12.6% mean annual
increase while expenses reached 17.9% respectively. Financial
resources of surgical cases increased 63% and pathological 25%
over the period 2002–2006, with a 27% income increase of
gynaecological AOC 21% of orthopaedics and 7% of ophthal-
mologic. Social funds do not reimburse AOC visits and patients’
out of pocket payments are the main sources of the AOC
funding. CONCLUSIONS: The operation of the AOC is encour-
aging, since it motivates health professionals to increase their
income, the hospital to exploit its full potential, offers patients
access to quality health care and covers unmet needs. The fact
that the operation of the AOC is based on patients’ direct pay-
ments remains a contradiction with the full coverage of the Greek
population for the provision of outpatient and impatient care in
the public sector. The lack of contracting negotiations between
the social insurance funds and the regional or hospital authorities
remains a problem for which the state owes to make policy
decisions, since the prices that are overwhelmed are almost com-
petitive to the private sector and overload disproportionately the
lower incomes.
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OBJECTIVES: To register the opinions of the employees as con-
cerned the supply chain management, which has been adopted
from hospitals. METHODS: Data were collected via a question-
naire and were processed by using the logistic regression method.
A total of 250 people were asked, all employees of health care
industry. RESULTS: Only 6.5% of the employees knows the cost
of the materials they use and 82.2% of them state that if they
were aware of the cost of the materials, they would certainly use
them more wisely. Also, 55.1% of the survey participants were
dissatisﬁed with the supply chain procedure and 55.6% would
rather each clinic or laboratory managed its supplying by itself.
Finally, 59.2% of the employees believes that there are no incen-
tives and control as far as hospital’s supply chain management.
CONCLUSIONS: There is a pressing need for the Greek hospi-
tals to re-organize their supply chain management in order to
reduce cost and offer quality health care.
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OBJECTIVES: To identify and analyse differences in the ﬁnanc-
ing of drugs between Autonomous Regions (AR) in Spain.
METHODS: A structured literature review on the IME, SciELO,
Doyma, Medline, Cochrane, national and AR ofﬁcial bulletins,
relevant Spanish scientiﬁc associations and AR health web pages,
and general and specialised press, up to June 15, 2007.RESULTS:
Nine AR legislative documents were identiﬁed, one national
working document, two press releases, one AR instruction, four
scientiﬁc articles and twoministerial documents. The most impor-
tant ﬁndings are as follows. Navarre and Andalusia ﬁnance some
drugs excluded from national public funding by the Royal Decree
1663/1998. Navarre, La Rioja, Extremadura and Madrid ﬁnance
smoking cessation products for the general population whereas
Cantabria and Catalonia only to some population groups. The
postcoital pill is ﬁnanced in Andalusia, Cantabria, Catalonia,
Canary Islands, Aragon, Asturias and Galicia. Erectile dysfunc-
tion drugs for patients with medullar damage are ﬁnanced in
Valencia, Murcia, Balearic Islands and Castile la Mancha. Differ-
ences have been detected in the ﬁnancing level (reduced co-
payment or free of charge) of several drugs for speciﬁc population
groups. Castile Leon has a reduced co-payment in antiviral and
antifungal drugs for cancer patients. Extremadura ﬁnances the
totality of the drugs to chronic patients younger than 14 years old
and families with more than 3 children, and Valencia ﬁnance total
treatment costs of tuberculosis drugs.CONCLUSIONS:There are
differences in the ﬁnancing of various pharmaceutical products
with low intrinsic value, life-style drugs and preventive drugs.
These inequalities may be perceived as a reason of inequity or may
reﬂect the intention to redistribute health care resources among
AR’s preferences. It is necessary to evaluate the preferences of the
population and the way these differences affect their health status.
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OBJECTIVES: Orphan medicinal product legislation was
adopted in Europe in 2000 with the aim of promoting the devel-
Abstracts A375
